Performance Metrics Comparison of CT with PET/CT Reports in Lymphoma Patient Follow-Up

The incidence of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) is rising annually, necessitating effective monitoring strategies. Computed Tomography (CT) and Positron Emission Tomography/Computed Tomography (PET/CT) are pivotal in this regard but differ in diagnostic accuracy due to their distinct imaging capabilities. This retrospective study evaluates 56 lymphoma patients using both modalities at Al-Ahli Hospital, Hebron, Palestine, from 2020 to 2023. Demographic and clinical data, alongside imaging findings, were analyzed. Results indicate PET/CT's superiority over CT alone, with higher sensitivity, specificity, precision, Accuracy where CT findings were 20%, 30.61%, 0.72%, and 30.34% retrospectively compared with PET/CT findings. Gender-specific analysis revealed marginal associations, highlighting the need for tailored imaging strategies. The study underscores PET/CT's enhanced diagnostic performance in lymphoma surveillance, advocating its use for improved patient management and outcomes. Further research could refine these findings, addressing the evolving landscape of lymphoma imaging.